AI assistant
PTC THERAPEUTICS, INC. — Director's Dealing 2016
Sep 27, 2016
31046_dirs_2016-09-27_7aee67b9-49ea-48d3-aca3-bfd63899d647.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2016-09-27
Reporting Person: Almstead Neil Gregory (EVP Research Pharma Ops & Tech)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-09-27 | Common Stock | M | 3414 | $10.85 | Acquired | 3414 | Direct |
| 2016-09-27 | Common Stock | M | 6586 | $10.85 | Acquired | 10000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2016-09-27 | Stock Option (Right to Buy) | $10.85 | M | 3414 | Disposed | 2023-05-15 | Common Stock (3414) | Direct |
| 2016-09-27 | Stock Option (Right to Buy) | $10.85 | M | 6586 | Disposed | 2023-05-15 | Common Stock (6586) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1295 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (40000) | 40000 | Direct |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (69550) | 69550 | Direct |
| Stock Option (Right to Buy) | $30.86 | 2026-01-03 | Common Stock (55000) | 55000 | Direct |
| Stock Option (Right to Buy) | $218.4 | 2022-01-10 | Common Stock (166) | 166 | Direct |
| Stock Option (Right to Buy) | $490.8 | 2021-04-27 | Common Stock (216) | 216 | Direct |
| Stock Option (Right to Buy) | $1149.6 | 2020-02-02 | Common Stock (200) | 200 | Direct |
| Stock Option (Right to Buy) | $451.2 | 2019-05-15 | Common Stock (200) | 200 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-04-01 | Common Stock (194) | 194 | Direct |
| Stock Option (Right to Buy) | $735.6 | 2018-01-25 | Common Stock (166) | 166 | Direct |
| Stock Option (Right to Buy) | $626.4 | 2017-04-18 | Common Stock (137) | 137 | Direct |
| Stock Option (Right to Buy) | $10.85 | 2023-05-15 | Common Stock (600) | 600 | Indirect |
| Stock Option (Right to Buy) | $27.05 | 2024-01-27 | Common Stock (1300) | 1300 | Indirect |
| Stock Option (Right to Buy) | $51.00 | 2025-01-01 | Common Stock (2060) | 2060 | Indirect |
| Restricted Stock Unit | $ | Common Stock (750) | 750 | Indirect | |
| Stock Option (Right to Buy) | $218.4 | 2022-01-10 | Common Stock (7) | 7 | Indirect |
| Stock Option (Right to Buy) | $490.8 | 2021-04-27 | Common Stock (7) | 7 | Indirect |
| Stock Option (Right to Buy) | $1149.6 | 2020-02-02 | Common Stock (1) | 1 | Indirect |
| Stock Option (Right to Buy) | $508.8 | 2019-10-07 | Common Stock (12) | 12 | Indirect |
Footnotes
F1: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on May 15, 2014 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on June 15, 2014.
F2: This option was granted on May 15, 2013 and vests over four years, with 25% of the shares underlying the option vested on December 31, 2013 and an additional 2.083% of the original number of shares underlying the option vesting monthly thereafter, beginning on January 31, 2014.
F3: This option was granted on January 28, 2014, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
F4: This option was granted on January 2, 2015, and vests over four years, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
F5: This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
F6: This restricted stock unit (RSU) award was granted on January 4, 2016 and vests in equal installments over four years on each anniversary of the grant date. Upon vesting, each RSU will convert into one share of common stock of the Issuer.
F7: Currently exercisable.